source: internationalization/trunk/TranslationSpreadsheets/WV-DIALOG-0246.txt@ 666

Last change on this file since 666 was 604, checked in by George Lilly, 15 years ago

Internationalization
File size: 7.9 KB
RevLine 
[604]1English French Notes Complete/Exclude
2DATE OF LAST CONTACT:
3TUMOR STATUS:
4ICD Revision:
5Place of Death:
6Care Center at Death:
7Autopsy:
8Autopsy Date/Time:
9Autopsy No:
10ICD Cause of Death:
11Cause of Death/Cancer:
12Date of Death:
13Path/autopsy:
14Religion:
15Marital Status at Dx:
16Occupation:
17 Last Date:
18Type of Tobacco user:
19 YR. Quit Tobacco Use:
20 Yrs. of Alcohol Use:
21 Drinks per-day:
22 Yr. Quit Drinking:
23Family Member with Cancer:
24Cancer:
25Primary Surgeon:
26Managing Physician:
27Following Physician:
28Other Physician 3:
29Other Physician 4:
30DX Date:
31Class of Case:
32Type of Reporting Source:
33Histology:
34Dx Facility:
35Text Histology:
36Grade:
37Tumor Marker 2:
38ICDO-Site:
39Referring Facility:
40Laterality:
41Transfer Facility:
42DX Confirmation:
43Primary Payer at Diagnosis:
44IP/OP status:
45Screening Result:
46Screening Date:
47Presentation at Cancer Conference:
48Date of Cancer Conference:
49Referral to Support Services:
50Site/Gp:
51 Primary Sequence No:
52Text-Primary Site Title:
53Text-Dx Proc-PE:
54Text-Dx Proc-X-ray/scan:
55Text-Dx Proc-Op:
56Text-Dx Proc-Lab Tests:
57Text-Dx Proc-Scopes:
58Text-Dx Proc-Path:
59Text Primary Site:
60Text Dx Proc-Phys.Exam:
61Text Dx Proc-Xray/Scan:
62Text Dx Proc-Operation:
63Text Dx Proc-Lab Tests:
64Text Dx Proc-Endoscopy:
65Text Dx Proc-Path/Cyto:
66Clinical TNM:
67Clinical T:
68Pathologic T:
69Clinical N:
70Pathologic N:
71Clinical M:
72Pathologic M:
73Clinical Stage Group:
74Staged By (Clin):
75Other Stage:
76Size of Tumor:
77Positive nodes:
78Peripheral Blood Inv.:
79Nodes Examined:
80Associated with HIV:
81Extension:
82Metastasis-1:
83Lymph Nodes:
84Metastasis-2:
85General Summary Stage:
86Metastasis-3:
87Dx/Stging/Palliative Proc:
88Surgery of Primary Site Date:
89Surgical Approach:
90Reconstruction/Restoration:
91- Text Rx-Surgery/No Surgery:
92- Text Rx-Other Cancer Directed Surgery:
93Surgical Margins:
94Reason for No Surgery:
95Radiation Date:
96Regional Dose:
97Radiation tx not administered
98NA, brachytherapy/radioisotopes administered
99Dose unknown/unknown if administered
100Regional Treatment Modality:
101Reason for No Radiation:
102Sequence:
103Radiation Treatment - (either radiation or prophylactic)
104Target Place:
105 Target Site:
106 Radiation Source:
107Total due to target:
108 Predominant FXN size:
109 Start Date:
110 Stop Date:
111- Text Rx-Rad (BEAM):
112- Text Rx-Rad-Other:
113Radiation Therapy to CNS DAte:
114Chemotherapy Date:
115Reason for No Chemotherapy:
116Text-Rx-Chemo:
117Hormone Therapy Date:
118Reason for No Hormone Therapy:
119Text-Rx-Hormone:
120Immunotherapy Date:
121Text-RX-Immunotherapy:
122Other Therapy Date:
123Text-Rx-Other:
124Protocol Eligibility Status:
125Protocol Participation:
126Text Remarks:
127Physician's Staging:
128MD:
129QA Selected:
130QA Review:
131QA Date:
132Recurrence Date:
133Distant Site 1:
134Type of 1st Recurrence:
135Distant Site 2:
136Distant Site 3:
137Subsequent Recurrence Date:
138Type of Subsequent Recurrence:
139********** Print Abstract-Brief **********
140Reporting Hospital:
141Date of First Contact:
142Histology:
143Acc/Seq Number:
144Medical Record Number:
145Telephone:
146Type of Reporting Source:
147Class of Case:
148Age at Dx:
149Birthplace:
150Facility referred from:
151Facility referred to:
152Date Dx:
153Following physician:
154Primary surgeon:
155Physician #3:
156Physician #4:
157Laterality:
158Diagnostic confirmation:
159Tumor size:
160Extension:
161Regional lymph nodes positive:
162Regional lymph nodes examined:
163Lymph nodes:
164SEER Summary Stage 2000:
165Sites of metastases:
166Clinical TNM:
167AJCC Stage (Clin):
168AJCC Stage (Path):
169FIRST COURSE OF TREATMENT SUMMARY:
170Dx/Staging/Palliative Proc:
171Surgery of primary site:
172Reason for no surgery:
173Radiation:
174Reason for no radiation:
175Hormone Therapy:
176Immunotherapy:
177Other treatment:
178Abstract Date:
179Abstracter:
180Date of Last Patient Contact:
181AVAILABLE CONTACTS
182***********DEATH INFORMATION**********
183Date:
184Cause of Death/Cancer:
185ICD Cause:
186Care Center:
187ICD Revision:
188Path/Autopsy (Gross & Micro):
189State Hospital No:
190IDCO SITE:
191GRADE:
192Sequence Number:
193DATE of LAST CONTACT:
194VITAL STATUS:
195ABSTRACTER:
196ABSTRACT DATE:
197Spanish origin:
198CONTACT NAME
199Follow-up Status:
200DATE LAST
201Site/Gp:
202PATIENT SUMMARY
203Date of Last Contact or Death:
204Autopsy Date/Time:
205Autopsy #:
206Cause of Death:
207Abstract Status:
208Date Case Completed:
209Primary Site:
210Patient Summary/Abstract for:
211** PATIENT IDENTIFICATION **
212Address at Dx:
213Accession No:
214Hospital No:
215Accession Yr:
216Primary Sequence No:
217Phone Residence:
218Marital Status DX:
219Agent Orange Exp:
220Ionizing Rad Exp:
221Chemical Exp:
222Asbestos Exp:
223Persian Gulf Svc:
224Middle East Svc:
225Somalia Svc:
226Comorbidity/Complication #1:
227Comorbidity/Complication #2:
228Comorbidity/Complication #3:
229Comorbidity/Complication #4:
230Comorbidity/Complication #5:
231Comorbidity/Complication #6:
232Primary Surgeon:
233Following Physician:
234** CANCER IDENTIFICATION **
235Date DX:
236Histology:
237AFIP Submission:
238Primary Site:
239** STAGE OF DISEASE AT DIAGNOSIS **
240Clinical TNM:
241Pathologic TNM:
242Clinical Stage Group:
243Pathologic Stage Group:
244Staged By (Clinical Stage):
245Staged By (Pathologic Stage):
246Other Stage:
247Pathologic Extension:
248Lymph Nodes:
249General Summary Stage:
250Metastasis-1:
251Metastasis-2:
252Metastasis-3:
253** FIRST COURSE OF TREATMENT **
254First Course of Treatment Date:
255 Date of No Treatment:
256 Surgery of Primary (F):
257 Surgery of Primary @Fac (F):
258 Surgical Margins:
259 Scope of LN Surgery (F):
260 Scope of LN Surgery @Fac (F):
261 Surg Proc/Other Site (F):
262 Surg Proc/Other Site @Fac (F):
263 Reason for No Surgery:
264 Regional Dose:
265 Regional Treatment Modality:
266Chemotherapy:
267Chemotherapy @Fac:
268Hormone Therapy:
269Hormone Therapy @Fac:
270Immunotherapy:
271Immunotherapy @Fac:
272Other Treatment:
273Other Treatment @Fac:
274Year Put on Protocol:
275** SUBSEQUENT THERAPY **
276Subsequent Treatment Date:
277Surgery of Primary Site:
278Hema Trans/Endocrine Proc:
279** FOLLOW-UP HISTORY **
280Cause of Death:
281 1998 Patient Care Evaluation Study of Prostate Cancer
2821998 Patient Care Evaluation Study of Prostate Cancer
2838. PRIMARY PAYER AT DIAGNOSIS
2849. FAMILY HISTORY OF PROSTATE CANCER
285 8. PRIMARY PAYER AT DIAGNOSIS
286 9. FAMILY HISTORY OF PROSTATE CANCER
287 TABLE I - GENERAL INFORMATION
2889 4. POSTAL CODE AT DIAGNOSIS.........
2899 7. SPANISH ORIGIN...................
29018 8. PRIMARY PAYER AT DIAGNOSIS.......
291657 9. FAMILY HISTORY OF PROSTATE CANCER
29210. CLASS OF CASE
29311. SYMPTOMS PRESENT AT INITIAL DIAGNOSIS
29412. INITIAL METHODS OF DIAGNOSIS
29513. DIAGNOSTIC EVALUATION
29614. RESULTS OF MOST RECENT PRE-TREATMENT PSA TEST
29718. BEHAVIOR CODE(ICD-O-2)
29820. BIOPSY PROCEDURE
29921. GUIDANCE OF BIOPSY TO PRIMARY
30022. BIOPSY APPROACH FOR PRIMARY
30123. BIOPSY OF OTHER THAN PRIMARY
30224. DIAGNOSTIC CONFIRMATION
303#################### #################### ####################
304#################### #################### ####################
305#################### #################### ####################
306#################### #################### ####################
307#################### #################### ####################
Note: See TracBrowser for help on using the repository browser.